-+ 0.00%
-+ 0.00%
-+ 0.00%
On November 19, Baitu Biotech officially released the AI drug safety evaluation system, which combines virtual cell models and toxicity prediction capabilities with non-clinical safety evaluation services, and extends AI prediction from the cellular level to animals, relying on safety prediction models such as “virtual monkeys”. According to reports, Baitu Biotech combines existing animal test data to explore virtual drug administration through safety prediction models such as “virtual monkeys.”
Share
Listen to the news
On November 19, Baitu Biotech officially released the AI drug safety evaluation system, which combines virtual cell models and toxicity prediction capabilities with non-clinical safety evaluation services, and extends AI prediction from the cellular level to animals, relying on safety prediction models such as “virtual monkeys”. According to reports, Baitu Biotech combines existing animal test data to explore virtual drug administration through safety prediction models such as “virtual monkeys.”
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending